000 01689 a2200457 4500
005 20250515124452.0
264 0 _c20081007
008 200810s 0 0 eng d
022 _a0021-9533
024 7 _a10.1242/jcs.027698
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVerbeek, Dineke S
245 0 0 _aPKC gamma mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling.
_h[electronic resource]
260 _bJournal of cell science
_cJul 2008
300 _a2339-49 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAmino Acid Sequence
650 0 4 _aCell Membrane
_xdrug effects
650 0 4 _aCell Nucleus
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aHeLa Cells
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aMAP Kinase Signaling System
_xdrug effects
650 0 4 _aMitogen-Activated Protein Kinase 1
_xmetabolism
650 0 4 _aMolecular Sequence Data
650 0 4 _aMutation
_xgenetics
650 0 4 _aProtein Kinase C
_xchemistry
650 0 4 _aProtein Structure, Tertiary
650 0 4 _aProtein Transport
_xdrug effects
650 0 4 _aSpinocerebellar Ataxias
_xenzymology
650 0 4 _aSubcellular Fractions
_xdrug effects
650 0 4 _aTetradecanoylphorbol Acetate
_xpharmacology
700 1 _aGoedhart, Joachim
700 1 _aBruinsma, Laurie
700 1 _aSinke, Richard J
700 1 _aReits, Eric A
773 0 _tJournal of cell science
_gvol. 121
_gno. Pt 14
_gp. 2339-49
856 4 0 _uhttps://doi.org/10.1242/jcs.027698
_zAvailable from publisher's website
999 _c18061335
_d18061335